Raise closed, search for fresh raises on Seedstage

Hopkins, MN

Funding for scaling AI-driven sleep therapy solutions for PTSD-related nightmares.

• FDA-Cleared Innovation: One of the only digital therapeutic devices approved for PTSD-related nightmare treatment.
• AI-Powered Technology: Utilizes biometric data to detect and disrupt nightmares in real time.
• Non-Drug Solution: Offers an effective alternative to traditional pharmaceutical treatments.
• Military & Veteran Focus: Expanding access within Veterans Affairs and Department of Defense healthcare systems.
• Clinical Validation: Ongoing trials to strengthen the evidence base for safety and efficacy.

NightWare is raising funds to expand its groundbreaking digital therapeutic solution designed to treat PTSD-related nightmares using AI-driven technology. Delivered through a smartwatch, this FDA-cleared device intervenes in real-time to disrupt nightmares without waking the user, providing a non-drug approach to improving sleep and mental health. The company plans to use the funds to support scaling operations, further clinical trials, and develop partnerships with healthcare providers, including military and veteran systems.

This fundraising initiative aims to enhance product accessibility and accelerate market penetration in the U.S., where demand for non-pharmaceutical sleep therapies is growing rapidly. Proceeds will also be allocated to advancing clinical validation and expanding its operational capacity to serve a broader demographic, including military personnel and trauma survivors. NightWare’s innovative approach combines AI technology with strategic partnerships to address a significant unmet need in the healthcare sector, improving quality of life for individuals impacted by PTSD.

Company Info

NightWare, Inc. provides an FDA-cleared, AI-driven smartwatch-based therapeutic for PTSD-related nightmares, improving sleep quality and mental health.

NightWare, Inc. is a healthcare technology company specializing in an innovative, AI-driven digital therapeutic designed to address PTSD-related nightmares. Delivered through a dedicated smartwatch, NightWare detects and disrupts nightmares in real time using biometric data, offering a non-drug solution that promotes restful sleep without waking the user. This FDA-cleared, prescription-only medical device has proven effective for veterans and active-duty military personnel, providing a significant improvement in mental health and sleep quality for over 1,500 individuals. NightWare partners with healthcare providers and government institutions, focusing on populations underserved by traditional treatments, and leverages its patented technology for personalized, effective interventions.

With a business model centered on prescription distribution, NightWare combines AI technology and clinical validation to serve both military and civilian healthcare markets. The company maintains strong intellectual property protections, including patents for its unique algorithms and methods, and collects extensive biometric data to refine its interventions. By integrating with systems such as the Veterans Affairs healthcare network and pursuing reimbursement agreements, NightWare is positioned to scale its operations and meet the demand for non-pharmaceutical PTSD treatments in a $13.2 billion market.